Add BrightSurf on Google Email

CAR T-Cell therapy outcomes similar across different socioeconomic levels among pediatric patients with ALL

A new study finds no significant difference in overall survival or complete remission rates between children and young adults with different levels of poverty exposure, regardless of their neighborhood opportunity. CAR T-cell therapy is equally effective for those from disadvantaged households as it is for those from more socioeconomic...

Increasing racism experienced by minority children in the USA

According to a new study published in the Journal of Osteopathic Medicine, parental reporting of racism experienced by children in minority groups in the USA increased from 6.7% in 2016 to 9.3% in 2020. Indigenous and Black children were particularly affected, with rates ranging from 10.8% to 15.7% and 9.69% to 15.04%, respectively.

SourceDe Gruyter·JournalJournal of Osteopathic Medicine·TypeSurvey·DateNov 10, 2022

CHOP researchers find COVID-19 vaccination leads to higher antibody levels than natural infection in both pregnant people and their babies

A study by Children's Hospital of Philadelphia researchers found that COVID-19 vaccination results in higher antibody concentrations compared to natural infection, providing robust protection for mothers during pregnancy. The study also suggests optimal vaccine timing can maximize the transfer of antibodies to babies.

SourceChildren's Hospital of Philadelphia·JournalJAMA Network Open·DateNov 9, 2022

Researchers examine rates of skin conditions among urban-living Indigenous children and young people in high-income countries

Urban-living Indigenous children and young people in high-income countries are disproportionately affected by atopic dermatitis and bacterial skin infections, which can lead to serious complications. This systematic review highlights the need for co-designed research with Indigenous communities to address these health inequities.

SourceWiley·JournalPediatric Dermatology·DateNov 9, 2022

Investigating COVID-19 deaths for children and young people

A new study confirms that COVID-19 deaths among children and young people are rare, with most fatalities occurring in those with severe neurodisability or compromised immune systems. The analysis of detailed data showed that half of COVID-19 deaths occurred within 30 days of infection.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateNov 8, 2022

Adverse pregnancy outcomes in women with inactive inflammatory bowel disease

A study by the University of Gothenburg found that women with inactive inflammatory bowel disease (IBD) have a higher risk of giving birth prematurely, particularly if they have microscopic inflammation in their intestinal mucosa. This association was not seen for other adverse pregnancy outcomes, such as growth restriction.

SourceUniversity of Gothenburg·JournalEClinicalMedicine·TypeData/statistical analysis·DateNov 7, 2022

Obesity drug helps teens lose weight, study finds

A new study published in the New England Journal of Medicine found that semaglutide, an approved obesity drug for adults, also helps adolescents with obesity lose weight and have healthier hearts. After 68 weeks, 72.5% of participants who received semaglutide had achieved at least 5% weight loss compared to just 17% on placebo.

SourceUniversity of Pittsburgh·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 2, 2022

Differences in state Medicaid programs for children with medical complexity may lead to care inequity

A new study from Ann & Robert H. Lurie Children's Hospital of Chicago highlights the variation in Medicaid programs for children with complex medical needs across states. The research reveals that these disparities can lead to delays in care and impact health outcomes for these vulnerable children.

Discovery of endocannabinoid gene mutation leads to identification of new, rare pediatric neurological disease

Researchers identified a new clinical syndrome, Neuro-Ocular DAGLA-related Syndrome (NODRS), in children with termination variants in the diacylglycerol lipase alpha (DAGLA) gene. The study found that enzymatic activity was preserved despite mis-localization of the truncated protein.

SourceRady Children's Institute for Genomic Medicine·JournalBrain·TypeObservational study·DateOct 27, 2022

Research finds that life-saving intervention is not risk-free in pediatric patients

Research found that blood transfusions following solid tumor removal in pediatric oncology patients are associated with higher rates of post-surgery infectious complications, shorter disease-free intervals, and tumor recurrence. The study aims to inform thoughtful use of blood transfusion and encourage multi-center data collection.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Pediatric Hematology/Oncology·TypeData/statistical analysis·DateOct 24, 2022

Infants who die unexpectedly in the first week might have different risk factors than those who die in the first month

A Rutgers study found that infants who died unexpectedly in the first week of life had different risk factors compared to those who died later. The study analyzed data from 2000 to 2015 and found that mothers of infants dying in the first week showed less evidence of common risk factors such as smoking during pregnancy.

SourceRutgers University·JournalThe Journal of Maternal-Fetal & Neonatal Medicine·TypeData/statistical analysis·DateOct 20, 2022

Substantial proportion of ethnically diverse children from low-resource backgrounds report long-term COVID-19 complications

A substantial proportion of ethnically diverse children from low-resource backgrounds with severe COVID-19 illness are reporting long-term complications. The study found that pediatric patients with private health insurance were 66% less likely to report long COVID symptoms versus those with government insurance.

SourceUniversity of Texas Health Science Center at Houston·JournalInternational Journal of Environmental Research and Public Health·DateOct 18, 2022

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

Researchers developed an alternative method of immunotherapy delivery, intraventricular treatment, to administer multiple therapeutic doses in mouse models of human metastatic medulloblastoma. This approach significantly extended survival and reduced toxicity compared to direct tumor inoculation methods.

SourceBrigham and Women's Hospital·JournalClinical Cancer Research·TypeExperimental study·DateOct 14, 2022

Family Heart Foundation study shows some children with homozygous familial hypercholesterolemia miss out on decades of life-saving treatment

Children with homozygous familial hypercholesterolemia are diagnosed earlier and have higher untreated LDL-C levels than adults, while those not identified early miss out on decades of life-saving treatment. This study emphasizes the need for universal screening to identify children with HoFH or heterozygous familial hypercholesterolemia.

Research examines which children were most severely sickened by COVID-19 and finds vaccinations were significantly protective

Research found that pre-existing illnesses and residence in the South region were most often associated with severe outcomes in children. Vaccination was significantly protective across all age groups, with infants having more severe illness than older children. Persistent health disparities across racial and geographic lines were also...

Scientists at IRB Barcelona and the PCCB develop a study model for Ewing sarcoma in the Drosophila fly

Scientists at IRB Barcelona and the PCCB have created a genetically tractable model of Ewing sarcoma using Drosophila flies expressing a mutant version of the human oncogene EWS-FLI. This model allows for the identification of critical proteins required for EWS-FLI's oncogenic function and potential therapeutic targets.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalPNAS Nexus·TypeExperimental study·DateOct 7, 2022

C-path to lead pre-consortium aimed at transforming, accelerating medical product development in alpha-1 antitrypsin deficiency

The Critical Path Institute has launched a pre-consortium collaboration with the FDA's CBER and CDER to accelerate medical product development in alpha-1 antitrypsin deficiency. The collaboration aims to define unmet needs in drug development and lay the groundwork for specific solutions.

SourceCritical Path Institute (C-Path)·TypeData/statistical analysis·DateOct 6, 2022

Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods

A new clinical trial found that the bionic pancreas device was more effective at maintaining blood glucose levels within normal range than standard-of-care management among people with type 1 diabetes. The device requires minimal user input and provides more automation, resulting in improved glycemic control.

SourceUniversity of Texas Health Science Center at San Antonio·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 5, 2022